Notably, these studies showed that higher retention and SUVR values for amyloid-beta proteins in specific brain regions was associated with APOE4 in PD subjects with mild cognitive impairment and/or dementia, highlighting APOE4’s potential role in influencing enhanced regional amyloid-beta pathology. The gene discussed is APOE; the disease is Cognitive impairment.